Compare $MRKR vs $VICP | Chartloom

Compare

$MRKR vs $VICP

Marker Therapeutics Inc · Vicapsys Life Sciences Inc

MRKR

Marker Therapeutics Inc

VICP

Vicapsys Life Sciences Inc

Compare $MRKR vs $VICP

Comparing Marker Therapeutics Inc and Vicapsys Life Sciences Inc

MRKRMarker Therapeutics Inc

VICPVicapsys Life Sciences Inc

MRKRMarker Therapeutics Inc

Market cap

$16M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.16x

Rev growth (TTM)

-46.2%

YTD performance

-36.9%

52W performance

-10.0%

FCF yield

-60.2%

VICPVicapsys Life Sciences Inc

Market cap

$18M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-63.3%

52W performance

-68.9%

FCF yield

0.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MRKR

VICP

Detailed metrics comparison

MRKR

Marker Therapeutics Inc

VICP

Vicapsys Life Sciences Inc

Market Cap

MRKR$16M

VICP$18M

Enterprise Value

MRKR$5M

VICP$18M

Price

MRKR$0.97

VICP$0.55

P/E Ratio

MRKRN/A

VICPN/A

P/S Ratio

MRKR6.93x

VICP0.00x

EV/Sales

MRKR2.08x

VICP0.00x

EV/EBITDA

MRKR0.00x

VICP0.00x

P/B Ratio

MRKR1.44x

VICPN/A

P/FCF Ratio

MRKRN/A

VICPN/A

EV/FCF

MRKR-0.50x

VICP0.00x

PEG Ratio

MRKRN/A

VICPN/A

Forward P/E (NTM)

MRKRN/A

VICPN/A

Forward P/S (NTM)

MRKR3.16x

VICPN/A

Revenue (TTM)

MRKR$2M

VICP$0

Revenue Growth (YoY)

MRKR-46.2%

VICPN/A

Forward Rev Growth

MRKR375.8%

VICP0.0%

Gross Margin (TTM)

MRKR0.0%

VICP0.0%

Operating Margin (TTM)

MRKR0.0%

VICP0.0%

EBITDA Margin (TTM)

MRKR-284.3%

VICP0.0%

Net Margin (TTM)

MRKR-236.6%

VICP0.0%

FCF Margin (TTM)

MRKR-417.6%

VICPN/A

Net Income (TTM)

MRKR$-6M

VICPN/A

FCF (TTM)

MRKR$-10M

VICP$0

EPS (TTM)

MRKR-$0.27

VICP$0.00

ROE (TTM)

MRKR-8086.0%

VICP0.0%

ROA (TTM)

MRKR-6705.0%

VICP0.0%

ROIC (TTM)

MRKR-8086.0%

VICP0.0%

Cash

MRKR$11M

VICP$90K

Debt

MRKR$0

VICP$579K

Net Cash/Debt

MRKR$11M

VICP$-489K

Current Ratio (TTM)

MRKR6.03x

VICP0.03x

Quick Ratio (TTM)

MRKR5.60x

VICP0.03x

Debt/Equity (TTM)

MRKR0.00x

VICP0.00x

Debt/Assets (TTM)

MRKR0.0%

VICP0.0%

Interest Coverage (TTM)

MRKRN/A

VICPN/A

Net Debt/EBITDA (TTM)

MRKR0.00x

VICP0.00x

Beta

MRKR1.59

VICP-3.98

52W Performance

MRKR-10.0%

VICP-68.9%

YTD Performance

MRKR-36.9%

VICP-63.3%

% from 52W High

MRKR-60.5%

VICP-68.9%

% from 52W Low

MRKR15.7%

VICP399.9%

Asset Turnover (TTM)

MRKR0.20x

VICP0.00x

FCF Yield (TTM)

MRKR-60.2%

VICP0.0%

Earnings Yield (TTM)

MRKR-34.1%

VICP0.0%

Dividend Yield (TTM)

MRKRN/A

VICPN/A

Rule of 40

MRKR-463.8

VICP0.0

EV/GP/RG

MRKRN/A

VICPN/A

Ticker research

View MRKR research View VICP research

Metric	MRKR Marker Therapeutics Inc	VICP Vicapsys Life Sciences Inc
Market & Valuation
Market Cap	$16M	$18M
Enterprise Value	$5M	$18M
Price	$0.97	$0.55
P/E Ratio	N/A	N/A
P/S Ratio	6.93x	0.00x
EV/Sales	2.08x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.44x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	-0.50x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.16x	N/A
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	-46.2%	N/A
Forward Rev Growth	375.8%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-284.3%	0.0%
Net Margin (TTM)	-236.6%	0.0%
FCF Margin (TTM)	-417.6%	N/A
Net Income (TTM)	$-6M	N/A
FCF (TTM)	$-10M	$0
EPS (TTM)	-$0.27	$0.00
ROE (TTM)	-8086.0%	0.0%
ROA (TTM)	-6705.0%	0.0%
ROIC (TTM)	-8086.0%	0.0%
Financial Health
Cash	$11M	$90K
Debt	$0	$579K
Net Cash/Debt	$11M	$-489K
Current Ratio (TTM)	6.03x	0.03x
Quick Ratio (TTM)	5.60x	0.03x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.59	-3.98
52W Performance	-10.0%	-68.9%
YTD Performance	-36.9%	-63.3%
% from 52W High	-60.5%	-68.9%
% from 52W Low	15.7%	399.9%
Efficiency & Yields
Asset Turnover (TTM)	0.20x	0.00x
FCF Yield (TTM)	-60.2%	0.0%
Earnings Yield (TTM)	-34.1%	0.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-463.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View MRKR research	View VICP research

Valuation

P/S Ratio

VICP

0.00x

MRKR

6.93x

EV/FCF

MRKR

-0.50x

VICP

0.00x

Growth & revenue

Revenue Growth TTM

MRKR

-46.2%

Forward Revenue Growth

MRKR

375.8%

VICP

0.0%

Profitability & performance

Gross Margin

MRKR

0.0%

VICP

0.0%

ROE

VICP

0.0%

MRKR

-8086.0%

FCF Yield %

VICP

0.0%

MRKR

-60.2%

52-Week Performance

MRKR

-10.0%

VICP

-68.9%

Detailed metrics comparison

MRKR

Marker Therapeutics Inc

VICP

Vicapsys Life Sciences Inc

Market Cap

MRKR$16M

VICP$18M

Enterprise Value

MRKR$5M

VICP$18M

Price

MRKR$0.97

VICP$0.55

P/E Ratio

MRKRN/A

VICPN/A

P/S Ratio

MRKR6.93x

VICP0.00x

EV/Sales

MRKR2.08x

VICP0.00x

EV/EBITDA

MRKR0.00x

VICP0.00x

P/B Ratio

MRKR1.44x

VICPN/A

P/FCF Ratio

MRKRN/A

VICPN/A

EV/FCF

MRKR-0.50x

VICP0.00x

PEG Ratio

MRKRN/A

VICPN/A

Forward P/E (NTM)

MRKRN/A

VICPN/A

Forward P/S (NTM)

MRKR3.16x

VICPN/A

Revenue (TTM)

MRKR$2M

VICP$0

Revenue Growth (YoY)

MRKR-46.2%

VICPN/A

Forward Rev Growth

MRKR375.8%

VICP0.0%

Gross Margin (TTM)

MRKR0.0%

VICP0.0%

Operating Margin (TTM)

MRKR0.0%

VICP0.0%

EBITDA Margin (TTM)

MRKR-284.3%

VICP0.0%

Net Margin (TTM)

MRKR-236.6%

VICP0.0%

FCF Margin (TTM)

MRKR-417.6%

VICPN/A

Net Income (TTM)

MRKR$-6M

VICPN/A

FCF (TTM)

MRKR$-10M

VICP$0

EPS (TTM)

MRKR-$0.27

VICP$0.00

ROE (TTM)

MRKR-8086.0%

VICP0.0%

ROA (TTM)

MRKR-6705.0%

VICP0.0%

ROIC (TTM)

MRKR-8086.0%

VICP0.0%

Cash

MRKR$11M

VICP$90K

Debt

MRKR$0

VICP$579K

Net Cash/Debt

MRKR$11M

VICP$-489K

Current Ratio (TTM)

MRKR6.03x

VICP0.03x

Quick Ratio (TTM)

MRKR5.60x

VICP0.03x

Debt/Equity (TTM)

MRKR0.00x

VICP0.00x

Debt/Assets (TTM)

MRKR0.0%

VICP0.0%

Interest Coverage (TTM)

MRKRN/A

VICPN/A

Net Debt/EBITDA (TTM)

MRKR0.00x

VICP0.00x

Beta

MRKR1.59

VICP-3.98

52W Performance

MRKR-10.0%

VICP-68.9%

YTD Performance

MRKR-36.9%

VICP-63.3%

% from 52W High

MRKR-60.5%

VICP-68.9%

% from 52W Low

MRKR15.7%

VICP399.9%

Asset Turnover (TTM)

MRKR0.20x

VICP0.00x

FCF Yield (TTM)

MRKR-60.2%

VICP0.0%

Earnings Yield (TTM)

MRKR-34.1%

VICP0.0%

Dividend Yield (TTM)

MRKRN/A

VICPN/A

Rule of 40

MRKR-463.8

VICP0.0

EV/GP/RG

MRKRN/A

VICPN/A

Ticker research

View MRKR research View VICP research

Metric	MRKR Marker Therapeutics Inc	VICP Vicapsys Life Sciences Inc
Market & Valuation
Market Cap	$16M	$18M
Enterprise Value	$5M	$18M
Price	$0.97	$0.55
P/E Ratio	N/A	N/A
P/S Ratio	6.93x	0.00x
EV/Sales	2.08x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.44x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	-0.50x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.16x	N/A
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	-46.2%	N/A
Forward Rev Growth	375.8%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-284.3%	0.0%
Net Margin (TTM)	-236.6%	0.0%
FCF Margin (TTM)	-417.6%	N/A
Net Income (TTM)	$-6M	N/A
FCF (TTM)	$-10M	$0
EPS (TTM)	-$0.27	$0.00
ROE (TTM)	-8086.0%	0.0%
ROA (TTM)	-6705.0%	0.0%
ROIC (TTM)	-8086.0%	0.0%
Financial Health
Cash	$11M	$90K
Debt	$0	$579K
Net Cash/Debt	$11M	$-489K
Current Ratio (TTM)	6.03x	0.03x
Quick Ratio (TTM)	5.60x	0.03x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.59	-3.98
52W Performance	-10.0%	-68.9%
YTD Performance	-36.9%	-63.3%
% from 52W High	-60.5%	-68.9%
% from 52W Low	15.7%	399.9%
Efficiency & Yields
Asset Turnover (TTM)	0.20x	0.00x
FCF Yield (TTM)	-60.2%	0.0%
Earnings Yield (TTM)	-34.1%	0.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-463.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View MRKR research	View VICP research